insphero.com valid
InSphero
For agents: InSphero: organoid and 3D in-vitro cell model company; articles on Gri3D technology and reproducible IC50 screening, plus code of conduct. Material is thin.
organoidsgri3ddrug-screeningic50in-vitro-models
- Authority
- 48 reach 6 · trust 10 · quality 17 · freshness 15
- Tier
- listed
- llms.txt
- https://insphero.com/llms.txt
- Sections
- 8
- Links
- 132
- Size
- 50502 bytes
- Popularity rank
- #610020
- Registered
- 2009-01-21
- Country
- Netherlands Hosting inference
- Hosting country
- Netherlands Hosting inference
- Country evidence
- No published address evidence collected yet
- Categories
- Science and research
- For agents
- Documentation: developer or product docs worth reading, nothing to call
- Inferred actions
- Search content Read documentation About these labels
- Audience
- business · agents can: search content, read docs · en
- First seen
- 2026-10-19T10:44:19.624Z
- Last checked
- 2026-10-21T09:48:12.510Z
- Badge
Their llms.txt
The beginning of the file, from our validated copy saved 2026-10-21T09:48:06.525Z. Cached copy · Source on insphero.com
Generated by Rank Math SEO, this is an llms.txt file designed to help LLMs better understand and index this website.
# InSphero
## Sitemaps
- [XML Sitemap](https://insphero.com/sitemap_index.xml): Includes all crawlable and indexable pages.
## Posts
- [How Gri3D® Technology and Automated Imaging at Single-Organoid Resolution Deliver Reproducible IC₅₀ Values Across Screening Campaigns](https://insphero.com/gri3d-enables-reproducible-values-in-organoid-screens/): Our CSO, Madhu Nag, writes about how Gri3D® technology and automated imaging at single-organoid resolution enable reproducible IC₅₀ values across screening campaigns, supporting more consistent and scalable organoid-based drug testing.
- [Co-Creating Confidence: Reflections on NAMs from the 16th Global Summit on Regulatory Science](https://insphero.com/nams-reflections-gsrs26-beijing/): InSphero CSO Madhu Nag reflects on the evolving role of New Approach Methodologies (NAMs) in regulatory science following the 16th Global Summit on Regulatory Science in Beijing. Drawing on discussions around validation, standardization, context of use, and reproducibility, the blog explores why regulatory confidence in NAMs must be built collaboratively and how co-creating the evidence base with regulators could help move these models toward broader regulatory use.
- [One Liver Platform, Multiple Questions: From Safety to Translation and Efficacy](https://insphero.com/one-liver-platform-for-safety-translation-efficacy/): The liver plays a central role throughout drug discovery, nonclinical development, and clinical translation. Its importance extends far beyond toxicity. As a major site of drug metabolism and bioactivation, the liver can contribute to influence drug efficacy and safety through metabolism-dependent effects, contribute to species-specific responses, and shape the exposure of other organs to parent compounds and their metabolites.
- [InSphero Appoints Dr. Olivier Frey as Chief Operating Officer and Chief Technology Officer](https://insphero.com/insphero-appoints-olivier-frey-coo-cto/): InSphero has appointed Dr. Olivier Frey as Chief Operating Officer and Chief Technology Officer, expanding his leadership role as the company continues to grow and scale. With nearly a decade at InSphero and deep expertise across microfluidics, BioMEMS, 3D in vitro models, and organ-on-chip technologies, Olivier will bring technology and operations into closer alignment. In his new role, he will help advance operational efficiency, digitalization, automation, and technology development across the organization.
- [Human-Relevant, Assay-Ready 3D In Vitro Models for More Predictive Drug Discovery Applications](https://insphero.com/human-relevant-assay-ready-3d-models-drug-discovery/): Human-relevant 3D in vitro models can provide valuable insights into drug safety, efficacy, and disease biology. Yet, establishing these physiologically relevant models internally often requires considerable time, specialist exper
…Related sites
Find similar publishers by meaning →
Other listed sites in Science and research. See the whole category →
| Domain | Title | Category | Country | Authority | llms.txt | llms-full.txt | Save |
|---|---|---|---|---|---|---|---|
| unesco.org | UNESCO | documentation Government and public services Science and research +1 | FR | 76 | ✓ | ✓ | |
| deepmind.google | Google DeepMind | documentation AI and machine learning Science and research +1 | US | 71 | ✓ | ✓ | |
| frontiersin.org | Frontiers (www.frontiersin.org) | documentation Science and research | IE | 71 | ✓ | ||
| pewresearch.org | Pew Research Center | documentation Science and research | US | 70 | ✓ | ||
| phys.org | Phys.org | documentation Science and research Media | US | 69 | ✓ | ||
| grandviewresearch.com | Grand View Research | transactional Data and analytics Business software +1 | US | 68 | ✓ | ||
| consensus.app | Consensus | interface Science and research AI and machine learning | — | 67 | ✓ | ✓ | |
| medicalxpress.com | Medical Xpress | documentation Healthcare Media +1 | US | 67 | ✓ |
Machine-readable: GET /v1/resolve?q=insphero.com · GET /v1/domain/insphero.com · this page as Accept: application/json or text/markdown · MCP lookup_domain
Automatically discovered from public files. Inclusion does not imply endorsement or publisher participation.
Own or manage this website?
If you own or manage insphero.com, you can update its listing and review file health, discovery activity and score history.
Manage this listing — optional
What verification unlocks
See how your site is discovered—and control what agents see.
- See your website in the map
Review your indexed topics, nearby publishers sharing headings, measured listing exposure and map snapshots in a private report for your website.
- Control what agents see
Edit your listing description, tags, public contact details and additional llms.txt paths. Publish your terms for automated access, attribution and pricing.
- Make your profile eligible for search
A valid, listed, unblocked, verified profile can appear in our publisher sitemap and become eligible for search-engine visibility. Search engines decide what to index and rank.
- Appear in our llms-full.txt
Eligible verified publishers are listed by name, with their file links and summaries, in the service overview agents can read.
Free. No account registration, backlink or payment required. Public discovery remains available without verification.
Let your coding agent verify it
If your coding agent is authorized to manage this website, paste these instructions into it.
Claim my listing on Agent Web Map for insphero.com:
1. POST https://agentwebmap.com/v1/sites/insphero.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://insphero.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/insphero.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/insphero.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verifyCorrections or removal requests: contact the directory.